Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ticlopidine hydrochloride (Ticlodix) is an effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
200 mg | $29 | In Stock | |
1 mL x 10 mM (in DMSO) | $30 | In Stock |
Description | Ticlopidine hydrochloride (Ticlodix) is an effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES. |
Targets&IC50 | P2 receptor:2 μM |
In vitro | Oral administration of Ticlopidine HCl in rats enhances the affinity of cyclase on platelet membranes for prostaglandin E1, subsequently activating both the basal and prostaglandin E1-stimulated without affecting the enzyme activity induced by adenosine or sodium fluoride. Ticlopidine HCl exhibits an inhibitory effect on platelet aggregation with an IC50 of 2 μM in males. |
In vivo | Ticlopidine HCl inhibits platelet aggregation by activating basal PGE1-induced cyclase activity, blocking the enhancement of cyclase activity induced by PGE2, thereby increasing platelet c-AMP levels, and suppressing prostaglandin synthesis from endogenous substrates. Additionally, it alters platelet membrane function and inhibits aggregation through the blockade of ADP receptors. |
Alias | Ticlopidine HCl, Ticlodone, Ticlodix |
Molecular Weight | 300.25 |
Formula | C14H15Cl2NS |
Cas No. | 53885-35-1 |
Smiles | Cl.Clc1ccccc1CN1CCc2c(C1)ccs2 |
Relative Density. | 1.37 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | H2O: 30 mg/mL (100 mM) DMSO: 65 mg/mL (216.49 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
H2O/DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.